Abstract
OBJECTIVE: Intravenous steroids improve the respiratory course in ventilator-dependent preterm infants but have adverse effects. We hypothesized that inhaled steroids would be as effective, but with less systemic effects.
STUDY DESIGN: We conducted a randomized, prospective trial comparing inhaled beclomethasone, either 400 or 800 μg/d, to intravenous dexamethasone in preterm infants dependent on conventional mechanical ventilation and supplemental oxygen at 2 weeks of age.
RESULTS: Seventy-eight infants were randomized. By day three of therapy, the intravenous steroid group had significantly decreased ventilator and oxygen requirements compared to either inhaled group. The inhaled 800-μg/d group trended toward more rapid decreases in ventilator and oxygen requirements than the 400-μg/d group. By day 14, all groups had similar reductions in ventilator and oxygen requirements. The incidence of adverse effects did not differ between groups.
CONCLUSIONS: In this small, randomized study, inhaled steroids conferred no advantages to intravenous steroids in the management of ventilator-dependent preterm infants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cummings JJ, D'Eugenio DB, Gross SJ . Controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia N Engl J Med 1989 320: 1505–10
Ng PC . The effective and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia Arch Dis Child 1993 68: 3 Spec No 330–6
Wilson NM, Silverman M . Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home Arch Dis Child 1990 65: 4 407–10
Konig P, Shatley M, Levine C, Mawhinney TP . Clinical observations of nebulized flunisolide in infants and young children with asthma and bronchopulmonary dysplasia Pediatr Pulmonol 1992 13: 209–14
LaForce WR, Brudno DS . Controlled trial of beclomethasone diproprionate by nebulization in oxygen and ventilator dependent infants J Pediatr 1993 122: 285–8
Cloutier MM . Nebulized steroid therapy in bronchopulmonary dysplasia Pediatr Pulmonol 1993 15: 2 111–6
Kamada AK, Szefler SJ . Inhaled therapy in infants: why not nebulize glucocorticoids? Pediatr Pulmonol 1992 13: 4 198–9
Gal P, Ransom JR, Carlos RQ et al. Beclomethasone for treating premature infants with BPD: Guidelines for patients selection (letter) J Pediatr 1993 123: 3 490–1
O'Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D . Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model Arch Dis Child 1992 67: 20–4
Rozycki H, Bryon P, Dailey K et al. Evaluation of a system for delivery of inhaled beclomethasone to intubated neonates Dev Pharmacol Ther 1991 16: 65–70
Tan KL . Blood pressure in very low birth weight infants in the first seventy days of life J Pediatr 1988 112: 266–70
Wilson DM, Baldwin RB, Ariagno RL . A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic–pituitary–adrenal axis in preterm infants J Pediatr 1988 113: 764–8
Thomas S, Murphy JF, Dyas J, Ryalls M, Hughes IA . Response to ACTH in the newborn Arch Dis Child 1986 61: 57–60
Mammel MC, Green TP, Johnson DE, Thompson TR . Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia Lancet 1983 i: 1356–8
Dimitriou G, Greenough A, Giffin FJ, Kavadia V . Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants Eur J Pediatr 1997 156: 51–5
Avent ML, Gal P, Ransom JL . The role of inhaled steroids in the treatment of bronchopulmonary dysplasia Neonat Network 1994 13: 3 63–9
Groneck P, Goetze-Spear B, Speer CP . Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease Pediatr Pulmonol 1999 27: 383–7
Ford LR, Willi SM, Hollis BW, Wright NM . Suppression and recovery of the neonatal hypothalamic–pituitary–adrenal axis after prolonged dexamethasone use J Pediatr 1997 131: 722–6
Cole CH, Shah B, Abbasi S et al. Adrenal function in premature infants during inhaled beclomethasone therapy J Pediatr 1999 135: 65–70
Korte C, Styne D, Merrit A, Mayes D, Wertz A, Helbock HJ . Adrenocortical function in the very low birthweight infant: improved testing sensitivity and association with neonatal outcome J Pediatr 1996 128: 257–63
O'Shea TM, Kothadia JM, Klinepeter KL et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age Pediatr 1999 104: 415–21
Yeh TF, Lin YJ, Huang CC et al. Early dexamethasone therapy in preterm infants: a follow-up study Pediatr 1998 101: 5 e7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suchomski, S., Cummings, J. A Randomized Trial of Inhaled Versus Intravenous Steroids in Ventilator-Dependent Preterm Infants. J Perinatol 22, 196–203 (2002). https://doi.org/10.1038/sj.jp.7210705
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210705
This article is cited by
-
Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis
BMC Pulmonary Medicine (2017)
-
Glucocorticoids in the treatment of neonatal meconium aspiration syndrome
European Journal of Pediatrics (2011)